Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands

BJOG : an International Journal of Obstetrics and Gynaecology
M K BakkerL T W De Jong-Van Den Berg

Abstract

To compare the prescription of drugs in women over a period from 2 years before until 3 months after pregnancy, regarding the type of drugs used and the fetal risk. A cohort study based on pharmacy records of women giving birth to a child between 1994 and 2003. The study was performed with data from the InterAction database, containing prescription-drug-dispensing data from community pharmacies. The study population included 5412 women for whom complete pharmacy records were available. Drugs were classified into three categories: (1) drugs for chronic conditions, (2) drugs for occasional use and (3) drugs for pregnancy-related symptoms and also classified according to the Australian classification system. The prescription rate was calculated as the number of women per 100 women who received one or more prescriptions for a given drug within a specified time period. About 79.1% of the women received at least one prescription during pregnancy. The prescription rate for most drugs for chronic diseases and for occasional use decreased during pregnancy, whereas, as expected, the prescription rate for pregnancy-related drugs increased. During the first trimester of pregnancy, 1.7% of all drugs prescribed for chronic conditions and 2.3...Continue Reading

References

Oct 8, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P C de JongT K Eskes
Feb 22, 1991·Pharmaceutisch Weekblad. Scientific Edition·L T De Jong-van den BergH Wesseling
May 21, 1999·European Journal of Clinical Pharmacology·C OlesenH T Sørensen
Aug 23, 2000·European Journal of Clinical Pharmacology·S DonatiM E Grandolfo
Nov 30, 2000·Lancet·I LacroixJ L Montastruc
Aug 16, 2001·Epidemiology·C OlesenUNKNOWN EuroMAP Group
Aug 16, 2002·Transplant Immunology·Monika Ostensen, Peter M Villiger
Oct 31, 2002·Thorax·S O ShaheenUNKNOWN ALSPAC Study Team
Nov 27, 2002·The American Journal of Psychiatry·Gregory E SimonRobert L Davis
Apr 18, 2003·European Journal of Clinical Pharmacology·Heli MalmUNKNOWN Finnish Register-Based Study
May 14, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Eric SchirmLolkje T W de Jong-van den Berg
Sep 3, 2004·American Journal of Obstetrics and Gynecology·Susan E AndradeRichard Platt
Sep 11, 2004·Journal of Clinical Epidemiology·Eric SchirmLolkje T W de Jong-van den Berg
Oct 14, 2004·European Journal of Clinical Pharmacology·Veronika Egen-Lappe, Joerg Hasford
Mar 5, 2005·American Journal of Obstetrics and Gynecology·Brian Chun-Fai-ChanAdrienne Einarson
Sep 10, 2005·American Journal of Obstetrics and Gynecology·Martha M WerlerMargaret A Honein

❮ Previous
Next ❯

Citations

Aug 8, 2008·European Journal of Clinical Pharmacology·Joshua J GagneJoseph S Gonnella
Apr 15, 2009·European Journal of Clinical Pharmacology·I LacroixC Damase-Michel
Feb 4, 2010·European Journal of Clinical Pharmacology·Xiaoming ZhuFangbiao Tao
Dec 23, 2011·European Journal of Clinical Pharmacology·Eivind YstromHedvig Nordeng
Sep 27, 2012·European Journal of Clinical Pharmacology·Ulrika NörbyLars L Gustafsson
Jun 30, 2012·International Journal of Clinical Pharmacy·Marina OdalovicLjiljana Tasic
Feb 7, 2013·International Journal of Clinical Pharmacy·Marina OdalovicLjiljana Tasic
Oct 10, 2013·Human Reproduction·Marleen M H J van GelderLolkje T W de Jong-van den Berg
Jan 12, 2010·Human Reproduction Update·Marleen M H J van GelderNel Roeleveld
Aug 19, 2010·The Journal of Antimicrobial Chemotherapy·Irene PetersenIrwin Nazareth
May 25, 2011·Clinical Epidemiology·Anne-Mette Bay BjørnVera Ehrenstein
Sep 6, 2011·Paediatric Drugs·Elisabeth Autret-LecaAnnie Pierre Jonville-Bera
Jul 21, 2012·European Journal of Clinical Pharmacology·P G J ter HorstB Wilffert
Jun 21, 2014·European Journal of Epidemiology·Huberdina P M SmedtsRégine P M Steegers-Theunissen
Feb 22, 2008·Journal of Perinatology : Official Journal of the California Perinatal Association·S W WenM C Walker
Jan 15, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marleen M H J van GelderMarian K Bakker
Jul 6, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Linda de JongeMarian K Bakker
Apr 13, 2012·Journal of Medical Economics·Janneke JentinkMaarten J Postma
Jan 29, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·M A BarakaA G Dupont
Jun 15, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Sipke T VisserMaarten J Postma
Mar 5, 2014·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Mohamed BarakaAlain G Dupont
Dec 22, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rachel A CharltonJohn G Weil
Jun 18, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Linda IrvineJosie M M Evans
Jun 15, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sophie CrespinChristine Damase-Michel
Jan 16, 2016·Journal of Midwifery & Women's Health·Susan M SinclairElizabeth M Cooper
Apr 5, 2014·Thérapie·Helle Kieler
Dec 12, 2012·Annals of Epidemiology·Sung-Shun WengHerng-Ching Lin
Oct 30, 2015·Pharmacoepidemiology and Drug Safety·Anick BérardHedvig Nordeng
Oct 28, 2011·Thérapie·Elisabeth Autret-LecaAnnie Pierre Jonville-Béra
Sep 20, 2011·Gynécologie, obstétrique & fertilité·C Hurault-DelarueC Damase-Michel
Jun 15, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·E RamosA Bérard
Aug 2, 2007·Birth Defects Research. Part A, Clinical and Molecular Teratology·Marian K BakkerLolkje T W de Jong-van den Berg
Oct 20, 2007·Pharmacoepidemiology and Drug Safety·Fokaline VroomLolkje T W de Jong-van den Berg
May 11, 2011·Arthritis Care & Research·Bindee KuriyaDaniel H Solomon
Apr 3, 2012·British Journal of Clinical Pharmacology·Maria RomørenHedvig Nordeng
Jun 1, 2011·Pharmacoepidemiology and Drug Safety·Miia ArtamaUNKNOWN Drugs and Pregnancy Study Group
May 25, 2013·Pharmacoepidemiology and Drug Safety·B WettermarkHt Sørensen
Jul 7, 2011·The British Journal of Dermatology·C-C ChiF Wojnarowska
Jul 21, 2011·Pharmacoepidemiology and Drug Safety·Jamie R DawSteven G Morgan
Dec 18, 2014·Basic & Clinical Pharmacology & Toxicology·Anne-Mette Bay BjørnMette Nørgaard
Jan 26, 2010·Pharmacoepidemiology and Drug Safety·Brian J ClearyDeirdre J Murphy
Aug 6, 2013·Pharmacoepidemiology and Drug Safety·Linda de JongeMarian K Bakker
Mar 26, 2014·Pharmacoepidemiology and Drug Safety·Rachel A CharltonCorinne S de Vries
Jul 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Linda de JongeMarian K Bakker
Sep 16, 2015·Clinical Pharmacokinetics·Angela ColbersFrans G M Russel
Oct 16, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·I M ZomerdijkB H Stricker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Obstetrics and Gynecology
Susan E AndradeRichard Platt
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Linda IrvineJosie M M Evans
Archives of Pediatrics & Adolescent Medicine
Michele L YbarraJanis Wolak
© 2022 Meta ULC. All rights reserved